Galenica Senese | Ipsen | Iqvia Solution Italy |Ist. Farm. Biologico Stroder | Istituto De Angeli |Istituto Ganassini | Istituto Gentili | Istituto Luso
Farmaco d’Italia | Italchimici | Italfarmaco | Italia| Itel Telecomunicazioni | Johnson & Johnson Medical| Johnson & Johnson | Kedrion | Kyowa Kirin |L. Molteni & C. F.lli Alitti | Laboratori Baldacci |Laboratori Guidotti | Laboratorio Farmaceutico C.T.
| Laboratorio Farmaceutico S.I.T. | Laboratorio
Terapeutico M.R. | Latina Pharma | Leo Pharma |Lifepharma | Lofarma | Lundbeck Italia | Malesci
Istituto Farm. | Mastelli | Master Pharma | Menarini
Biotech | Merck Serono | Merqurio Pharma |Mitim | Moderna Italy | Monico | Morganceutical| MSD Italia | Mundipharma Pharmaceuticals |Neopharmed Gentili | Ner viano Medical Sciences |Noos | Norgine Italia | Novar tis Farma | Novavax
Italia | Novo Nordisk | Octapharma Italy | Omikron
Italia | Organon Italia | Otsuka Pharmaceutical Italy| Patheon Italia | Pfizer Italia | Pfizer | Pharmafar| Pharmanutra | Philogen | PIAM Farmaceutici |Pierre Fabre Pharma | Pierrel | Polichem | Polifarma| Promedica | Recordati Ind.Chim.Farm. | Recordati
Rare Diseases Italy | Roche | Sanofi | Santen Italy| Savio Pharma Italia | Scharper | Ser vier Italia| Shionogi | SIFI | Simesa | Sintesy Pharma |So.Se.Pharm | Società Prodotti Antibiotici | Sofar |Stewart Italia | Swedish Orphan Biovitrum | Takeda
Italia | Takeda Manufacturing Italia | Temmler Italia| Teva Italia | Tillotts Pharma Italy | UCB Pharma| Valpharma International | Ver tex Pharmaceuticals| Viatris Italia | ViiV Healthcare | Vim G.
Ottaviani | Visufarma | Wyeth Lederle | Zambon |Zeta Farmaceutici

M E M B E R C O M PA N I E S

PHARMACEUTICAL
INDUSTRY
IN ITALY
FACT S AND F IG U RESFARMINDUSTRIA
Largo del Nazareno 3/8 - 00187 Roma
T: 06 675801
Avenue de la Joyeuse Entrée 1 - B1040 Bruxelles
T: +32 2 2861255

farmindustria@farmindustria.it
www.farmindustria.it

Printed with data and info
available as of 30 June 2024

A.C.R.A.F. Az Chim. Riunite Angelini Francesco |A. Menarini Ind. Farm. Riunite | Abbvie |Abiogen Pharma | Acarpia Farmaceutici | Adare
Pharmaceuticals | Addenda Pharma | Advanced
Accelerator Applications Italy | Aeffe Farmaceutici |Aerosol Ser vice Italiana | Aesculapius Farmaceutici| Aesica Pharmaceuticals | Alexion Pharma Italy| Alfasigma | Alk-Abelló | Allergan | Almirall |Altergon Italia | Amgen | Aptuit | Astellas Pharma |Astrazeneca | Avara Liscate Pharmaceutical Ser vices| Bausch & Lomb Iom | Baxter Italy| Bayer Healthcare
Manufacturing | Bayer | Bial Italia | Biogen Italia |Biologici Italia Laboratories | Biopharma | Boehringer
Ingelheim Italia | Bracco Imaging | Bristol-Myers
Squibb | Bruschettini | BSP Pharmaceuticals | C.O.C.
Farmaceutici | Catalent Italy | Chiesi Farmaceutici| Chiesi Italia | Corden Pharma | Cosmo | Crucell
Italy | CSL Vifor| CSO Pharmitalia | D.M.G. Italia |Daiichi Sankyo Italia | Dompé Farmaceutici | Doppel
Farmaceutici | Ecupharma | Eisai | Eli Lilly Italia| E-Pharma Trento | Esseti Farmaceutici | Euromed| F.I.R.M.A. | Farmaceutici Damor | Farmaka |Farmalabor | Farmila-Thea Farmaceutici | Fatro |Ferring | Fine Foods & Pharmaceuticals N.T.M. |Fulton Medicinali | Galapagos Biopharma Italy |Galderma Italia | Galileo Research | GB Pharma| GE Healthcare | Gentium | Gilead Sciences| Giuliani | Glaxosmithkline Manufacturing |Glaxosmithkline | Glaxosmithkline Vaccines | Grifols
Italia | Grünenthal Italia | Guerbet | Hikma Italia| I.B.I. Giovanni Lorenzini | I.B.N. Savio | IBSA
Farmaceutici Italia | ICI Rende | IDI Farmaceutici| Incyte Biosciences Italy | Industria Farmaceutica

Researchand innovation
for people

People,our strength

Creatingvaluein Italy

Leaders
in the green
transition

HOPE FOR A CURE IS GROWINGQUALITY EMPLOYMENTINDUSTRIAL VALUE

GREEN ECONOMY

Leader in Europe, together with Germany and France and a

The pharmaceutical industry is at the top of the man-strategic asset of the economy with:ufacturing sectors for concrete actions in environ-billion for exports

mental sustainability, such as the reduction of water
consumption, the production of waste in the production
process, the use of plastic in packaging and fossil fuels

IN THE WORLD

23K new medicines in development

70K employees
153K employees, considering suppliers as well
+9% employment growth in the last 5 years (nationalis becoming increasingly personalized for patients

90% share of employees with a degree or school-

90 new medicines authorized in 2023 (the annual
average in the 5, pre-Covid years was 49)

Hope for new treatments is growing and medicine

LIVE MORE AND BETTERIN ITALY−25% reduction in mortality
in the last 20 years

average: +3%)

leaving diploma

45% share of women (industry average: 29%), oftenwith top roles
Sustainable and inclusive development models are increasingly widespread in companies+1 million people survived after a cancer diagnosis in the last 10 years

270K people cured thanks to innovative medicines
against hepatitis C

YOUTH AND TRAINING+19% under 35 in the last five years, involved in training,professional development activities, with a particular focus on
multidisciplinary and soft skills

135 medicines currently in use against rare diseases(there were 7 in 2007)

THE CLOCK OF LIFE

+150% growth in exports in the last ten years (+130%EU average)

EFFICIENCYINVESTMENTS, INNOVATION AND DIGITAL TRANSITION€3,6 billion of investments in 2023 in Italy, of which€1.6 billion investments in high-tech plants and €2 billion in R&D (of−35% reduction in mortality from chronic diseases
in the last 20 years€52 billion in production value in 2023, of which €49

Work-life balance is increasingly at the heart of compa-out in hospitals, with benefits in access to new treatments, growth ofskills and savings for the NHS)

45% of patients who use at least one app in the healthcare field
39% doctors who use tele-visit services
42% of doctors who use the Electronic Healthcare Record
MORE ATTRACTIVENESS TO GROW

+1 year growth in average life expectancy in the last

nies: to promote work-life balance, psycho-physical well-be-$1.7 trillion globally in R&D investments between

3 years thanks to research, greater appropriateness of careing, support for parenting and caregivers, enhancement of2023 and 2028 (the highest investment in any industrial sector). This

diversity, training and healthcare

is an opportunity for growth and development that Italy canand quality of the National Health Service

last 10 years (manufacturing average: -19%). In the same
period, the use of energy from renewable sources has
increased fivefold

which over €700 million investments in clinical research carriedFirst in Italy for Open Innovation

CORPORATE WELFARE FOR PEOPLE-32% reduction in energy consumption in theseize, thanks to its scientific and industrial excellence, if it implements
policies to increase the attractiveness and competitiveness of the system

MATERIAL EFFICIENCYAt the forefront of the “circular approach”, a modelthat generates innovation, increases efficiency andcompetitiveness, and is good for businesses, the environment and the communities where they operate